Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The long-recognised role of the eye is to generate an image of the world using rod and cone photoreceptors. Recent research has led to the discovery that the eye contains another class of photoreceptor called photosensitive retinal ganglion cells (pRGCs).

These specialised neurons detect environmental brightness and regulate circadian rhythms, sleep, alertness, mood and even pupil size.

These findings have transformed our understanding of how the eye works and helped to redefine our assessment, treatment and care of individuals with eye disease.

Our aims are to:

  1. Determine which ocular diseases are implicated in the development of SCRD.
  2. In patients in whom SCRD is identified, to assess response to therapeutic interventions and develop evidence-based guidelines for the management of these conditions.
  3. Identify defects in the melanopsin signalling pathway of humans, in both healthy volunteers and patients with ocular disease.

Our team

Selected Publications

FOR MORE ARCHIVED PUBLICATIONS CLICK HERE

Funders

Current Projects

The Oxford Eye Hospital has an excellent reputation in the field of clinical research and attracts trainees from around the world. The ocular disease research is funded by large grant-giving bodies, NIHR/HTA, and commercial sponsors. See list of current projects.